Roboclinic Review
Best for: AI-first GLP-1 care with all-in compounded semaglutide and tirzepatide plans
Roboclinic is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care. It sells compounded semaglutide from $179/mo (injections) or $249/mo (oral tablets) and compounded tirzepatide from $299/mo, with the consult, prescription, and delivery bundled into one all-in price that stays the same at every dose. Clinical review and pharmacy fulfillment run through OpenLoop Health.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Top-rated alternatives to Roboclinic
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Roboclinic at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $179/mo ('$179/m' 12-month plan price (strikethrough from $249); month-to-month is $299/mo, 3-month $249/mo. Live-verified 2026-07-10)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Roboclinic
Each dimension is scored algorithmically from Roboclinic’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.5/10At $179/mo, Roboclinic runs about 5% above the $170 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Roboclinic offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.7/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.6/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-07-10).
Accessibility10%
6.4/10Roboclinic's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.2/10Roboclinic provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Roboclinic review
Last checked 2026-07-10- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
GLP-1 medications Roboclinic offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
'$179/m' 12-month plan price (strikethrough from $249); month-to-month is $299/mo, 3-month $249/mo. Live-verified 2026-07-10
Oral compounded semaglutide tablets; 12-month plan $249/mo, 3-month $279/mo, month-to-month $299/mo. Live-verified 2026-07-10
'$299/m' 12-month plan price (strikethrough from $399); month-to-month is $399/mo, 3-month $349/mo. Live-verified 2026-07-10
Ready to get started?
Plans and promotions change often — check Roboclinic's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
- One all-in price bundles the provider consult, prescription, and delivery
- Offers both injectable and oral (tablet) compounded semaglutide
- 'Same price, every dose' means your cost does not rise as the dose increases
- AI-first intake with board-certified provider review; no insurance necessary
- LegitScript-certified; clinical care and pharmacy fulfillment coordinated through OpenLoop Health
- Cancel anytime from your profile
Watch-outs
- Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
- Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
- No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
- Refunds limited to your most recent billing cycle; none for used or partially used periods
- Operated by BrickFi, Inc., a newer brand with limited independent track record
Is Roboclinic worth it? Our verdict
Roboclinic positions itself around one thing: AI-first GLP-1 care with all-in compounded semaglutide and tirzepatide plans. It runs $179/month, flat across every dose. Its standout is a needle-free oral option, which very few providers offer.
Beyond the core GLP-1 program, Roboclinic leans on Oral & Injectable, AI-First Intake, and LegitScript Verified.
How much Roboclinic actually costs
- Compounded semaglutide — $179/month
- Compounded semaglutide — $249/month
- Compounded tirzepatide — $299/month
That's roughly in line with the ~$170/month median across the GLP-1 providers we track.
For a direct comparison, Sunlight runs semaglutide and tirzepatide from $159/month — worth pricing against Roboclinic before you commit.
Medications: what Roboclinic prescribes
Roboclinic prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Roboclinic's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Roboclinic is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Roboclinic is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Bodybuilding Health+ is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Roboclinic is a solid telehealth option with balanced features and pricing.
Ready to start with Roboclinic?
Starting at $179/month. See current pricing and start your free consultation.
Roboclinic might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Roboclinic review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Roboclinic's current pricing
Plans start at $179/month. Start your free consultation to check eligibility and today's price.